Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
about
Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural formsNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationRecent treatment advances and novel therapeutic approaches in epilepsyThe riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy.Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target DrugsGanaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorderThe potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Phosphorylation of GABAA receptors influences receptor trafficking and neurosteroid actions.Pediatric super-refractory status epilepticus treated with allopregnanolone.Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.Hippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.Rapid throughput analysis demonstrates that chemicals with distinct seizurogenic mechanisms differentially alter Ca2+ dynamics in networks formed by hippocampal neurons in culture.Potassium channel activator attenuates salicylate-induced cochlear hearing loss potentially ameliorating tinnitusNALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsComparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus.Imaging Brain Inflammation: If We Can See It, Maybe We Can Treat It.New drug classes for the treatment of partial onset epilepsy: focus on perampanel.Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.Neuroactive steroids for the treatment of status epilepticusAnti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideMulticomponent synthesis and anticonvulsant activity of monocyclic 2,6-diketopiperazine derivativesInvolvement of gap junction channels in the pathophysiology of migraine with aura.Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment.Investigating psychotropic properties of antiepileptic drugs.Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.Current and emerging treatments for absence seizures in young patientsUnderstanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies.Brivaracetam for the treatment of epilepsy in adults.Disease modification in epilepsy: from animal models to clinical applications.Exploring novel AEDs from drugs used for treatment of non-epileptic disorders.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).Altered gene expression profile in a mouse model of SCN8A encephalopathy.Ganaxolone: A New Treatment for Neonatal Seizures.Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase.Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors.Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.
P2860
Q24564596-C137D2F4-BE31-471B-93E8-F7333DF106F7Q26823386-62FEB11E-202B-439C-95B4-CEA6C81B4D38Q26824512-2EE3BA7E-EEC0-4AB5-830F-8492BD32FBDEQ27339255-64DC523F-CCF4-4F2B-A5C3-CE82DC8698A5Q27692644-99402A24-D411-4BF6-84FF-2E8E02538E42Q28074736-D8B87B3F-A051-4ED0-8F50-BA39A1542280Q30428666-975CEDDF-AC6A-4EE3-9F51-79FEC429A03FQ30576758-E3208FDE-C818-4CD5-AA14-93028BCD83FEQ34053899-C4ACE972-94BE-4C4E-AB46-B19D3CCF7560Q34445859-7638CBCF-A5F7-4600-9653-EA9847274CEAQ34795269-6286A7CE-7B32-41E8-A353-0F35C6AA9C6FQ35008940-8ED357E9-6229-43D1-97A4-BEF43AD35AD2Q35198051-E54B1CEB-F696-4F66-9EC7-1F00FB75FB87Q35296511-B7FBED15-0D12-4083-BA1C-F890DB650D7AQ35665990-13226B05-309B-4EB3-8661-6F2EFE5A27C7Q36244649-98815A67-FD15-42F5-A5A5-4374E8C9E3A0Q36343295-C3880685-BC6D-4CB2-AE97-F18E5E7D500CQ36567422-BF4A5DBF-7B2F-4D36-AA74-DF9561EEC98AQ37014640-1A5FD9B5-099A-4BD2-A900-3B3675862AF8Q37131951-80F9591B-8764-4367-B578-27FDDE5572D4Q37169261-9FC0EC5F-DABD-4D31-BD29-94EE7AF19234Q37340703-141CBFBA-C531-47AF-BB6E-1A8681A037BAQ37569837-0C1CFBCA-B8D1-44EB-A70C-0C0C89F12F6FQ37601409-E9524EA8-A95C-40FA-BC17-C59EBD195EA0Q38105151-A98BBE01-A6A3-44BB-85C6-AD77502F0172Q38112212-3C963780-C156-4EB9-A12C-FBD00C1B53E6Q38115721-390B20FF-C8F0-4152-B908-E154D31BAD15Q38124030-3287E70C-2C44-4AD4-B311-A5348D84BA2CQ38162945-8EA88274-9345-4707-AF52-2E3CA8341DBEQ38195636-16271F08-2EC5-432D-8930-1592E94EF009Q38450069-4CD7663B-6286-4C16-9DFE-E8EA97E314A5Q38787286-8E03CA9F-0908-4F98-A359-88B095CCE4B8Q39006241-0E8FB06B-9ABC-420E-B0E7-F0E4DE3ADD07Q39194220-CF2AF292-F8D3-4C03-BB0D-063803CFC8FFQ41525348-2511CD70-1401-4D27-BCEC-1F2EE5F30AD1Q41660900-B08BDBD1-8F07-441C-8482-2DB2BD2A0D81Q41902175-E1E1716F-5683-4473-896F-25230C6EEF6EQ42212418-7A60074D-D013-45CD-B57F-941FB45E1503Q46375658-95405459-213C-47D5-A2C4-1551EAB526AFQ46501785-1DCF3C0B-84C2-4FD4-8212-A07ED2FE4002
P2860
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@en
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@nl
type
label
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@en
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@nl
prefLabel
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@ast
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@en
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@nl
P2093
P50
P3181
P1433
P1476
Progress report on new antiepi ...... th Eilat Conference (EILAT XI)
@en
P2093
H. Steve White
René H. Levy
Svein I. Johannessen
P3181
P356
10.1016/J.EPLEPSYRES.2012.10.001
P407
P577
2013-01-01T00:00:00Z